Injectable · Scalp · Autologous · Hair Loss
PRP for Hair
How this page was made
This page was written with AI assistance and reviewed against the sources listed under References below. It is general information only, not medical advice. See our full
disclaimer for how SHEA creates and reviews treatment information.
01
What it is
Platelet-rich plasma, or PRP, is prepared from a person's own blood. Blood is drawn and processed, usually by centrifugation, to produce a plasma fraction containing a higher concentration of platelets. For hair treatment, the prepared PRP is injected into areas of the scalp affected by hair loss.
Platelets release signaling proteins and growth factors involved in tissue repair and cell activity. PRP has therefore been studied as a treatment for hair loss, particularly androgenetic alopecia, also called pattern hair loss.
PRP does not create new hair follicles. Research instead looks at whether treatment can improve measures such as hair density in areas where follicles are still present.
This page covers PRP injections for hair loss. See the PRP for Skin page for its cosmetic skin use.
02
Why people consider it
- They have androgenetic alopecia, or pattern hair loss, and are considering an injectable treatment
- Hair is thinning but follicles are still present in the affected area
- They prefer a treatment prepared from their own blood rather than an injected pharmaceutical product
- They are considering PRP alongside established treatments such as topical minoxidil and want to understand what evidence exists for combining them
03
What the experience is like
A small amount of blood is drawn and processed to separate the platelet-rich plasma. The prepared PRP is then injected at multiple points across the area of the scalp being treated.
Protocols differ considerably. Studies have used different blood-processing systems, platelet concentrations, activation methods, injection techniques, treatment intervals, and numbers of sessions. There is no single standardized PRP protocol used across the published literature.
Temporary pain, tenderness, swelling, redness, bleeding, or bruising can occur around the injection sites. Because PRP is prepared from the patient's own blood, it differs from treatments involving an externally manufactured injectable product, but the injection procedure itself still carries risks.
Hair changes are assessed over time rather than immediately after treatment. The number and spacing of sessions vary, so it is worth asking a clinic exactly what protocol it uses and why.
04
Limitations & considerations
PRP is not one standardized treatment
How PRP is prepared varies substantially between studies and clinics. Platelet concentration, centrifugation method, leukocyte content, activation, injection technique, and treatment schedule may differ. This makes it difficult to assume that results from one PRP protocol will apply to another.
- The strongest evidence is for androgenetic alopecia. Evidence should not automatically be transferred to every cause of hair loss
- A diagnosis matters before treatment because diffuse shedding, autoimmune alopecia, scarring alopecia, pattern hair loss, and other causes of hair loss are different conditions
- PRP does not create new follicles, so expectations should be different in an area with long-standing complete hair loss than in an area where hair is thinning but follicles remain
- Preparation methods vary substantially, and published studies have not established one universally superior PRP formulation or protocol
- A 2025 meta-analysis found a significant increase in hair density within the activated-PRP subgroup but not the non-activated subgroup. The difference between the two activation subgroups was not itself shown to be statistically significant, so this does not establish that activation itself produces better results
- Blood disorders, platelet abnormalities, anticoagulant medication, active infection, and other medical conditions may affect whether an injectable blood-derived treatment is appropriate and should be discussed with the treating clinician
- Evidence for combining PRP with minoxidil suggests a possible additional benefit, but the certainty of that evidence has been rated low to very low
- No specific increase in hair density or other outcome can be guaranteed
Evidence note
A 2025 systematic review and meta-analysis identified 43 randomized controlled trials involving 1,877 participants with alopecia. Across studies reporting hair density, PRP was associated with an overall increase in hair density, but heterogeneity was very high. The review did not find a significant overall effect on hair thickness. All three authors are affiliated with BTI Biotechnology Institute, which develops and commercializes PRGF-Endoret, an activated platelet-rich plasma technology. This affiliation is relevant because the review separately analyzed activated and non-activated PRP.
The same review examined PRP activation specifically. Activated PRP showed a statistically significant increase in hair density within its own subgroup, while the non-activated subgroup did not reach significance on its own. The difference in response between activated and non-activated PRP was not itself shown to be statistically significant, however. Significance within one subgroup and not another does not by itself demonstrate a statistically significant difference between the subgroups. The authors also noted inconsistent reporting of PRP composition and leukocyte content across included studies, which limited analysis of how preparation influenced outcomes.
A separate 2024 systematic review and meta-analysis focused specifically on androgenetic alopecia and included 14 randomized studies involving 431 participants, with 13 studies included in the quantitative analysis. PRP was associated with increased hair density compared with placebo, but the included studies were highly heterogeneous, evidence certainty was rated low, and publication bias was identified.
Evidence for combining PRP with topical minoxidil is even less certain. A 2024 systematic review found five randomized trials comparing PRP plus minoxidil with minoxidil alone. Hair density favored the combination at several follow-up points, but three of the five trials were judged at high risk of bias, and the authors rated the overall certainty of evidence as low to very low.
References
Peer-reviewed literature.
1. Anitua E, Tierno R, Alkhraisat MH. Platelet-Rich Plasma in the Management of Alopecia: A Systematic Review and Meta-Analysis of Clinical Evidence. Dermatology and Therapy, 2025;15(11):3213–3252.
Peer-reviewed · Systematic review and meta-analysis (43 RCTs, n=1,877) · All authors affiliated with BTI Biotechnology Institute / PRGF-Endoret
2. Kieling C, Konzen D, Zanella D, Valente NYS. Is autologous platelet-rich plasma capable of increasing hair density in patients with androgenetic alopecia? A systematic review and meta-analysis of randomized clinical trials. Anais Brasileiros de Dermatologia, 2024;99(6):847–862.
Peer-reviewed · Systematic review and meta-analysis (14 studies, n=431) · Low-certainty evidence · Publication bias identified
3. Yao J, Zhu L, Pan M, Shen L, Tang Y, Fan L. The additive value of platelet-rich plasma to topical Minoxidil in the treatment of androgenetic alopecia: A systematic review and meta-analysis. PLOS ONE, 2024;19(8):e0308986.
Peer-reviewed · Systematic review and meta-analysis (5 RCTs) · Low to very low certainty